⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DAWN News
Day One Biopharmaceuticals, Inc. Common Stock
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)
prnewswire.com
DAWN
Servier et Day One Biopharmaceuticals annoncent un accord d'acquisition qui renforce le portefeuille de Servier dans les cancers rares USA - Français USA - English
prnewswire.com
DAWN
DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
DAWN
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio
prnewswire.com
DAWN
Form 8-K
sec.gov
DAWN
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
globenewswire.com
DAWN
Form 8-K
sec.gov
DAWN
Form 8-K
sec.gov
DAWN
Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance
globenewswire.com
DAWN
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
globenewswire.com
DAWN